2025-12-24 15:26:58

U.S. stocks showed mixed performance today, with the Dow Jones Industrial Average falling slightly by 0.1%, the S&P 500 index dropping 0.03%, and the Nasdaq Composite decreasing 0.02%, reflecting a generally stable market.

Important developments have emerged in the chip sector. Intel's stock price declined by 3% due to Nvidia suspending testing of its 18A process technology. This move highlights the uncertainties in advanced process development and has prompted the market to reconsider chip technology routes.

The consumer goods sector received positive news. Nike's stock price rose by 3%, as reports indicated that Apple CEO Tim Cook recently made a significant purchase, buying 50,000 shares of Nike for $2.95 million. This personal investment is seen as a bullish signal for Nike's prospects.

The pharmaceutical M&A market is active. Denavie Pharmaceuticals' stock soared by 38%, driven by the announcement that pharmaceutical giant Sanofi will acquire the company for $2.2 billion. This deal underscores the strategic focus of major pharma companies on innovative therapies.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

10 Likes

Reward
10
5
Repost
Share

Comment

0/400

ShamedApeSeller

· 7h ago

Intel's recent situation is really tough, dropping directly by 3% after Nvidia's move. Cook's move to buy Nike really impresses me; he's truly leading by example as an investor. Pharmaceutical mergers and acquisitions are the real winners today, with a 38% surge—absolutely remarkable. The competition over chip development strategies is quite interesting; it's hard to say who will ultimately win. Compared to consumer goods, it seems the latter is more aggressive this time.

View OriginalReply0

MEVHunterZhang

· 7h ago

NVIDIA's move is too aggressive, Intel is directly stunned Cook is spending his own money to buy Nike, he must be very optimistic 38%? Denavie Pharmaceuticals is really taking off The chip industry is very complicated; who is genuine and who is fake will have to be seen in the follow-up Sanofi's acquisition action feels like paving the way for the future

View OriginalReply0

DegenRecoveryGroup

· 7h ago

Intel's recent performance is indeed disappointing, with NVIDIA dropping 3% immediately after suspending testing... Cook really knows how to operate; spending 2.95 million on Nike—are they sending us a signal? Sanofi's 2.2 billion acquisition shows that the pharmaceutical sector still has promising prospects. The overall market is like this; just wait for the next opportunity.

View OriginalReply0

HodlKumamon

· 7h ago

Cook's move is brilliant. Investing $2.95 million in Nike, from a different perspective, is essentially using real money to validate his judgment. The data speaks for itself~ Nvidia suspends Intel's 18A testing, indicating that this path might really have issues. Bear feels that the market is re-pricing risk, so there's no need to panic excessively(´▽`ʃ♡ƪ) DenaV increased by 38% overnight, my goodness. Whether Sanofi's acquisition can outperform the average growth of the pharmaceutical sector depends on subsequent clinical data support. Statistical significance is very important~ Overall, the Dow fell 0.1%, and the Nasdaq fell 0.02%. Such slight fluctuations are actually a good time for dollar-cost averaging. Bear's DCA plan continues to be executed. Cook's increased stake in Nike indicates that consumer goods still have vitality. Although the overall market is stable, there are indeed opportunities in certain areas. The key is to find the right direction~

View OriginalReply0

MetaverseLandlord

· 8h ago

Nvidia's move is ruthless, directly cutting off the root Cook spends 2.95 million to buy Nike? Is he hinting something to us 38%? Denavi is taking off, Sanofi really dares to spend money The chip industry is too muddy, who can survive and swim out is still uncertain Consumer stocks and pharmaceutical stocks take turns performing, this rhythm of the US stock market is quite interesting Intel is being rubbed on the ground, the 18A process dream is shattered Cook's personal investments are so aggressive, indicating a strong confidence in Nike's future The wave of mergers and acquisitions is coming, an era of big fish eating small fish The fluctuations are not big, but the sector differentiation is obvious, this is the highlight Sanofi moved too quickly, pharmaceutical giants are rushing to innovate drugs

View OriginalReply0